Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Coronavirus disease 2019 (COVID-19) increases the risk of several non-pulmonary complications such as acute myocardial injury, renal failure or thromboembolic events. A possible unifying explanation for these phenomena may be the presence of profound endothelial dysfunction and injury. This review provides an overview on the association of endothelial dysfunction with COVID-19 and its therapeutic implications. Endothelial dysfunction is a common feature of the key comorbidities that increase risk for severe COVID-19 such as hypertension, obesity, diabetes mellitus, coronary artery disease or heart failure. Preliminary studies indicate that vascular endothelial cells can be infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and evidence of widespread endothelial injury and inflammation is found in advanced cases of COVID-19. Prior evidence has established the crucial role of endothelial cells in maintaining and regulating vascular homeostasis and blood coagulation. Aggravation of endothelial dysfunction in COVID-19 may therefore impair organ perfusion and cause a procoagulatory state resulting in both macro- and microvascular thrombotic events. Angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) and statins are known to improve endothelial dysfunction. Data from smaller observational studies and other viral infections suggests a possible beneficial effect in COVID-19. Other treatments that are currently under investigation for COVID-19 may also act by improving endothelial dysfunction in patients. Focusing therapies on preventing and improving endothelial dysfunction could improve outcomes in COVID-19. Several clinical trials are currently underway to explore this concept.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Self-citationHamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“Indeed, ACE2 is expressed abundantly on vascular endothelial cells of both small and large arteries and veins [56].”
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I. M., Miao, V. N., Tzouanas, C. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.035 · Cited by 2,284
Puntmann, V. O., Carerj, M. L., Wieters, I., Fahim, M., Arendt, C., Hoffmann, J., Shchendrygina, A., Escher, F., Vasa-Nicotera, M., Zeiher, A. M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.3557 · Cited by 2,208
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., Bertuzzi, A., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.024 · Cited by 2,054
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e2 · Cited by 1,404
COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome
Gattinoni, L., Coppola, S., Cressoni, M., Busana, M., Rossi, S., & Chiumello, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0817le · Cited by 1,396
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237
The Assessment of Endothelial Function: From Research Into Clinical Practice
Flammer, A. J., Anderson, T., Celermajer, D. S., Creager, M. A., Deanfield, J., Ganz, P., Hamburg, N. M., Lüscher, T. F., Shechter, M., Taddei, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.093245 · Cited by 1,153
Self-citationThe ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Goshua, G., Pine, A. B., Meizlish, M. L., Chang, C.-H., Zhang, H., Bahel, P., Baluha, A., Bar, N., Bona, R. D., Burns, A. J., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30216-7 · Cited by 1,110
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
Reynolds, H. R., Adhikari, S., Pulgarin, C., Troxel, A. B., Iturrate, E., Johnson, S. B., Hausvater, A., Newman, J. D., Berger, J. S., Bangalore, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008975 · Cited by 1,063
ST-Segment Elevation in Patients with Covid-19 — A Case Series
Bangalore, S., Sharma, A., Slotwiner, A., Yatskar, L., Harari, R., Shah, B., Ibrahim, H., Friedman, G. H., Thompson, C., Alviar, C. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009020 · Cited by 844
Pathogenesis of COVID-19 from a cell biology perspective
Mason, R. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.00607-2020 · Cited by 841
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
Lindner, D., Fitzek, A., Bräuninger, H., Aleshcheva, G., Edler, C., Meissner, K., Scherschel, K., Kirchhof, P., Escher, F., Schultheiss, H.-P., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.3551 · Cited by 827
Brunner, H., Cockcroft, J. R., Deanfield, J., Donald, A., Ferrannini, E., Halcox, J., Kiowski, W., L??scher, T. F., Mancia, G., Natali, A., et al. (2005) · Journal of Hypertension · doi:10.1097/00004872-200502000-00001 · Cited by 753
Endothelial cell control of thrombosis
Yau, J. W., Teoh, H., & Verma, S. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0124-z · Cited by 691
Hürlimann, D., Forster, A., Noll, G., Enseleit, F., Chenevard, R., Distler, O., Béchir, M., Spieker, L. E., Neidhart, M., Michel, B. A., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037521.71373.44 · Cited by 574
Self-citationTargeting vascular (endothelial) dysfunction
Daiber, A., Steven, S., Weber, A., Shuvaev, V. V., Muzykantov, V. R., Laher, I., Li, H., Lamas, S., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13517 · Cited by 501
Zhang, X.-J., Qin, J.-J., Cheng, X., Shen, L., Zhao, Y.-C., Yuan, Y., Lei, F., Chen, M.-M., Yang, H., Bai, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.015 · Cited by 474
Colmenero, I., Santonja, C., Alonso‐Riaño, M., Noguera‐Morel, L., Hernández‐Martín, A., Andina, D., Wiesner, T., Rodríguez‐Peralto, J. L., Requena, L., & Torrelo, A. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19327 · Cited by 421
de Abajo, F. J., Rodríguez-Martín, S., Lerma, V., Mejía-Abril, G., Aguilar, M., García-Luque, A., Laredo, L., Laosa, O., Centeno-Soto, G. A., Ángeles Gálvez, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31030-8 · Cited by 408
Gao, C., Cai, Y., Zhang, K., Zhou, L., Zhang, Y., Zhang, X., Li, Q., Li, W., Yang, S., Zhao, X., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa433 · Cited by 403
Redox Biology of Respiratory Viral Infections
Khomich, O. A., Kochetkov, S. N., Bartosch, B., & Ivanov, A. V. (2018) · Viruses · doi:10.3390/v10080392 · Cited by 378
Fosbøl, E. L., Butt, J. H., Østergaard, L., Andersson, C., Selmer, C., Kragholm, K., Schou, M., Phelps, M., Gislason, G. H., Gerds, T. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.11301 · Cited by 377
Hippisley-Cox, J., Young, D., Coupland, C., Channon, K. M., Tan, P. S., Harrison, D. A., Rowan, K., Aveyard, P., Pavord, I. D., & Watkinson, P. J. (2020) · Heart · doi:10.1136/heartjnl-2020-317393 · Cited by 351
Eto, M., Kozai, T., Cosentino, F., Joch, H., & Lüscher, T. F. (2002) · Circulation · doi:10.1161/01.cir.0000015465.73933.3b · Cited by 330
Oxidants and Antioxidants in Viral Diseases: Disease Mechanisms and Metabolic Regulation
Peterhans, E. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.962s · Cited by 235
Acute kidney injury in SARS-CoV-2 infected patients
Fanelli, V., Fiorentino, M., Cantaluppi, V., Gesualdo, L., Stallone, G., Ronco, C., & Castellano, G. (2020) · Critical Care · doi:10.1186/s13054-020-02872-z · Cited by 203
Statins as Regulators of Redox State in the Vascular Endothelium: Beyond Lipid Lowering
Margaritis, M., Channon, K. M., & Antoniades, C. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5430 · Cited by 165
Pandemic Influenza: A Potential Role for Statins in Treatment and Prophylaxis
Fedson, D. S. (2006) · Clinical Infectious Diseases · doi:10.1086/505116 · Cited by 164
De Spiegeleer, A., Bronselaer, A., Teo, J. T., Byttebier, G., De Tré, G., Belmans, L., Dobson, R., Wynendaele, E., Van De Wiele, C., Vandaele, F., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.06.018 · Cited by 164
Ramasubbu, K., Estep, J. D., White, D. L., Deswal, A. M., & Mann, D. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.009 · Cited by 159
Shahin, Y., Khan, J. A., Samuel, N., & Chetter, I. C. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.044 · Cited by 152
Reriani, M. K., Dunlay, S. M., Gupta, B., West, C. P., Rihal, C. S., Lerman, L. O., & Lerman, A. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711398430 · Cited by 144
Cardiovascular effects of flavanol-rich chocolate in patients with heart failure
Flammer, A. J., Sudano, I., Wolfrum, M., Thomas, R., Enseleit, F., Periat, D., Kaiser, P., Hirt, A., Hermann, M., Serafini, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr448 · Cited by 139
Self-citationPoor, H. D., Ventetuolo, C. E., Tolbert, T. M., Chun, G. B., Serrao, G. W., Zeidman, A. D., Dangayach, N. S., Olin, J. W., Kohli-Seth, R. D., & Powell, C. A. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.44 · Cited by 129
Ruiz‐Limón, P., Ortega, R., de la Rosa, I. A., Abalos-Aguilera, M. D. C., Pérez‐Sánchez, C., Jiménez, Y., Peralbo‐Santaella, E., Font, P., Ruiz, D., Ferrín, G., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.003 · Cited by 127
Retinal microvascular dysfunction in heart failure
Nägele, M. P., Barthelmes, J., Ludovici, V., Cantatore, S., von Eckardstein, A., Enseleit, F., Lüscher, T. F., Ruschitzka, F. T., Sudano, I., & Flammer, A. J. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx565 · Cited by 125
Self-citationOxidative stress-mediated effects of angiotensin II in the cardiovascular system
Wen, H., Gwathmey, J. K., & Xie, L. (2012) · World Journal of Hypertension · doi:10.5494/wjh.v2.i4.34 · Cited by 121
Sodhi, C. P., Nguyen, J. M., Yamaguchi, Y., Werts, A. D., Lu, P., Ladd, M. R., Fulton, W. B., Kovler, M. L., Wang, S., Prindle, T., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900579 · Cited by 113
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
Flacco, M. E., Martellucci, C. A., Bravi, F., Parruti, G., Cappadona, R., Mascitelli, A., Manfredini, R., Mantovani, L. G., & Manzoli, L. (2020) · Heart · doi:10.1136/heartjnl-2020-317336 · Cited by 113
Müller, D. N., Mervaala, E. M. A., Dechend, R., Fiebeler, A., Park, J.-K., Schmidt, F. H., Theuer, J., Breu, V., Mackman, N., Luther, T., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64523-3 · Cited by 106
Simvastatin improves endothelial function in patients with rheumatoid arthritis
Hermann, F., Forster, A., Chenevard, R., Enseleit, F., Hürlimann, D., Corti, R., Spieker, L. E., Frey, D., Hermann, M., Riesen, W., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.006 · Cited by 105
Self-citationEndothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome
Naegele, M., Flammer, A. J., Enseleit, F., Roas, S., Frank, M., Hirt, A., Kaiser, P., Cantatore, S., Templin, C., Fröhlich, G., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.008 · Cited by 103
Self-citationPenny, W. F., Ben‐Yehuda, O., Kuroe, K., Long, J., Bond, A., Bhargava, V., Peterson, J. F., McDaniel, M. B., Juliano, J., Witztum, J. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01180-3 · Cited by 91
Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1
Holy, E. W., Akhmedov, A., Speer, T., Camici, G. G., Zewinger, S., Bonetti, N. R., Beer, J. H., Lüscher, T. F., & Tanner, F. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.755 · Cited by 65
Self-citationLi, S., Wu, Y., Yu, G., Xia, Q., & Xu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090217 · Cited by 58
Cited by
Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000096 · Cited by 1,142
Xu, S.-W., Ilyas, I., & Weng, J.-P. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00998-0 · Cited by 440
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Nombel, A., Fabien, N., & Coutant, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773352 · Cited by 262
Insight into the Evolving Role of PCSK9
Maligłówka, M., Kosowski, M., Hachuła, M., Cyrnek, M., Bułdak, Ł., Basiak, M., Bołdys, A., Machnik, G., Bułdak, R. J., & Okopień, B. (2022) · Metabolites · doi:10.3390/metabo12030256 · Cited by 41
Metadata
- Authors
- Nägele, M. P., Haubner, B., Tanner, F. C., Ruschitzka, F., & Flammer, A. J.
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 314
- Pages
- 58-62
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W3092997163
- Cited by
- 300
- References
- 55
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.